Brandon Capital
Melbournebrandoncapital.vc
Overview
Brandon Capital is a life sciences venture capital firm that invests in early-stage and emerging biomedical technologies in Australasia, the UK, and the US.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AdvanCell | Jul 2026 | Series D | Co-investor |
| OncoRes Medical | Feb 2026 | VC Round | Lead |
| Lumonus | Nov 2025 | Series B | Co-investor |
| ENA Respiratory | Oct 2025 | Series B | Co-investor |
| NRG Therapeutics | Sep 2025 | Series B | Co-investor |
Key People
Katharine Giles
Venture Partner
Roberto Solari
Venture Partner
Trent Munro
Venture Partner and Head of Biocatalyst for Queensland
Chris Smith
Partner
Jonathan Tobin
Partner
Melissa McBurnie
Partner Head Of Impact, Investment Manager
Robert Sicilia
Head of Investor Relations
Alex Delbridge
Principal Investment Team
Bob Soh
Senior Investment Manager
Duncan Mackintosh
Senior Investment Manager, Investment Manager
Jess Smith
Investment Manager
Katherine Jackman
Investment Manager
Mara Macdonald
Investment Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
